Concepedia

Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Richard B. Warren, Catherine Smith, Zenas Z N Yiu, Darren M. Ashcroft, A. David Burden, Mark Lunt, Kathleen McElhone, Anthony D. Ormerod, Caroline Owen, Nick J. Reynolds,

Journal of Investigative Dermatology · 2015 · 369 citations · 25 references

DOI

Concepts

References

25

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

Munir Pirmohamed, Sally James, Shaun Meakin et al. · BMJ · 2004 · 3.2K citations · Full text

, , +10

Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

C.E.M. Griffiths, Bruce Strober, Peter van de Kerkhof et al. · New England Journal of Medicine · 2010 · 851 citations

, , +13

Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

Emma Davies, Christopher F. Green, Stephen Taylor et al. · PLoS ONE · 2009 · 694 citations · Full text

, , +12

Influence of Patient Sex and Gender on Medication Use, Adherence, and Prescribing Alignment with Guidelines

Marie Manteuffel, Sophy Williams, William Chen et al. · Journal of Women s Health · 2013 · 411 citations

, , +17

Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris

Robert Gniadecki, B K Bang, Lars Erik Bryld et al. · British Journal of Dermatology · 2014 · 278 citations

, , +16